George Dunbar
Director/Board Member at CAPRICOR THERAPEUTICS, INC.
Net worth: 71 675 $ as of 2024-03-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Anthony Bergmann | M | 38 |
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a private company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | 13 years |
Linda Marbán | M | 60 |
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a private company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | 19 years |
David Musket | M | 66 |
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a private company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | 12 years |
Karen Krasney | F | 71 |
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a private company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | 13 years |
Brandon H. McNaughton | M | - |
Akadeum Life Sciences, Inc.
Akadeum Life Sciences, Inc. Medical/Nursing ServicesHealth Services Akadeum Life Sciences, Inc. provides diagnostics services. The firm is developing a new product that uses BACS (buoyancy-activated cell sorting) to acquire target cells from biological samples by using tiny floating spheres called ?microbubbles? and disposable microbubble collectors. The company was founded by Brandon H. McNaughton and John Younger in March 2014 and is headquartered in Ann Arbor, MI. | 10 years |
Louis Manzo | M | 86 |
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a private company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | 18 years |
John Younger | M | - |
Akadeum Life Sciences, Inc.
Akadeum Life Sciences, Inc. Medical/Nursing ServicesHealth Services Akadeum Life Sciences, Inc. provides diagnostics services. The firm is developing a new product that uses BACS (buoyancy-activated cell sorting) to acquire target cells from biological samples by using tiny floating spheres called ?microbubbles? and disposable microbubble collectors. The company was founded by Brandon H. McNaughton and John Younger in March 2014 and is headquartered in Ann Arbor, MI. | 10 years |
Earl Collier | M | 76 | 11 years | |
Frank Litvack | M | 68 |
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a private company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | 12 years |
Karimah Es Sabar | F | 66 | 3 years | |
Doug Neal | - | - |
Akadeum Life Sciences, Inc.
Akadeum Life Sciences, Inc. Medical/Nursing ServicesHealth Services Akadeum Life Sciences, Inc. provides diagnostics services. The firm is developing a new product that uses BACS (buoyancy-activated cell sorting) to acquire target cells from biological samples by using tiny floating spheres called ?microbubbles? and disposable microbubble collectors. The company was founded by Brandon H. McNaughton and John Younger in March 2014 and is headquartered in Ann Arbor, MI. | 10 years |
Paul Auwaerter | M | 62 | 1 years | |
Kristi Elliott | M | - | 3 years | |
Michael Linderman | M | - |
Akadeum Life Sciences, Inc.
Akadeum Life Sciences, Inc. Medical/Nursing ServicesHealth Services Akadeum Life Sciences, Inc. provides diagnostics services. The firm is developing a new product that uses BACS (buoyancy-activated cell sorting) to acquire target cells from biological samples by using tiny floating spheres called ?microbubbles? and disposable microbubble collectors. The company was founded by Brandon H. McNaughton and John Younger in March 2014 and is headquartered in Ann Arbor, MI. | - |
Vanessa Kelchner | F | - |
Akadeum Life Sciences, Inc.
Akadeum Life Sciences, Inc. Medical/Nursing ServicesHealth Services Akadeum Life Sciences, Inc. provides diagnostics services. The firm is developing a new product that uses BACS (buoyancy-activated cell sorting) to acquire target cells from biological samples by using tiny floating spheres called ?microbubbles? and disposable microbubble collectors. The company was founded by Brandon H. McNaughton and John Younger in March 2014 and is headquartered in Ann Arbor, MI. | 6 years |
Thomas Lyle Copmann | M | 71 | 9 years | |
William Hyun | M | - |
Akadeum Life Sciences, Inc.
Akadeum Life Sciences, Inc. Medical/Nursing ServicesHealth Services Akadeum Life Sciences, Inc. provides diagnostics services. The firm is developing a new product that uses BACS (buoyancy-activated cell sorting) to acquire target cells from biological samples by using tiny floating spheres called ?microbubbles? and disposable microbubble collectors. The company was founded by Brandon H. McNaughton and John Younger in March 2014 and is headquartered in Ann Arbor, MI. | 8 years |
Heidi Hassen | F | - | 14 years | |
Philip Gotwals | M | 61 | 1 years | |
Dan Kidle | M | - |
Akadeum Life Sciences, Inc.
Akadeum Life Sciences, Inc. Medical/Nursing ServicesHealth Services Akadeum Life Sciences, Inc. provides diagnostics services. The firm is developing a new product that uses BACS (buoyancy-activated cell sorting) to acquire target cells from biological samples by using tiny floating spheres called ?microbubbles? and disposable microbubble collectors. The company was founded by Brandon H. McNaughton and John Younger in March 2014 and is headquartered in Ann Arbor, MI. | 3 years |
Doug Neal | M | - |
Akadeum Life Sciences, Inc.
Akadeum Life Sciences, Inc. Medical/Nursing ServicesHealth Services Akadeum Life Sciences, Inc. provides diagnostics services. The firm is developing a new product that uses BACS (buoyancy-activated cell sorting) to acquire target cells from biological samples by using tiny floating spheres called ?microbubbles? and disposable microbubble collectors. The company was founded by Brandon H. McNaughton and John Younger in March 2014 and is headquartered in Ann Arbor, MI. | - |
David DeMartino | M | - |
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a private company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | - |
Michael Kelliher | M | 47 | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Darlene P. Horton | M | 62 | 1 years | |
Gerald D. Brennan | M | 73 | 4 years | |
Brian D. Gibson | M | 45 | 3 years | |
Scott Durbin | M | 55 | 1 years | |
Daron Evans | M | 50 | 6 years | |
R. Douglas Armstrong | M | 70 | 19 years | |
Louis J. Grasmick | M | 99 |
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a private company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | 10 years |
Peter Morgan Kash | M | 62 | - | |
Rachel Smith | M | 45 |
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a private company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | 5 years |
Sharon M. Watling | M | 60 | - | |
Andrew Hamer | M | 62 |
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a private company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | 2 years |
Paul Anthony Mieyal | M | 55 | 6 years | |
Jeffrey L. Cleland | M | 59 |
Targesome, Inc.
| 1 years |
Steven Quay | M | 73 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 8 years |
Ronald M. Cresswell | M | 89 | 4 years | |
Harold C. Urschel | M | 94 | 3 years | |
Pedro Granadillo | M | 77 | 6 years | |
Joshua Kazam | M | 47 | 14 years | |
Gregory W. Schafer | M | 59 | 3 years | |
Anthony H. Davies | M | - | 1 years | |
Gary Zweiger | M | - |
Akadeum Life Sciences, Inc.
Akadeum Life Sciences, Inc. Medical/Nursing ServicesHealth Services Akadeum Life Sciences, Inc. provides diagnostics services. The firm is developing a new product that uses BACS (buoyancy-activated cell sorting) to acquire target cells from biological samples by using tiny floating spheres called ?microbubbles? and disposable microbubble collectors. The company was founded by Brandon H. McNaughton and John Younger in March 2014 and is headquartered in Ann Arbor, MI. | 2 years |
Arie Belldegrun | M | 74 | 4 years | |
Michael B. Stewart | M | - |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | - |
Mark Low | M | - |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 3 years |
Gregory Sessler | M | 71 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 5 years |
Peter C. Alain | M | - | - | |
Siegfried S. Rogy | M | - | - | |
Deborah D. Ascheim | M | 59 | 3 years | |
Michelle Griffin | F | 58 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 4 years |
Tariq Warsi | M | - | - | |
Daniel Paulson | M | - | - | |
Mary G. Bolton | M | - |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 1 years |
Alan Fuhrman | M | 67 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 4 years |
Sheldon A. Schaffer | M | - | - | |
Elaine Waller | M | 72 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 5 years |
Ronnda L. Bartel | M | 65 | 7 years | |
Craig Steven Eudy | M | 58 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 6 years |
Elmar R. Burchardt | M | - | 4 years | |
Leland Gershell | M | 52 | 2 years | |
Richard Daifuku | M | 71 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 4 years |
Benjamin Goux | M | 51 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 3 years |
Houman D. Hemmati | M | - | - | |
Michelle Burris | F | 58 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 4 years |
Dwight Winstead | M | 75 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 13 years |
Robert E. Ivy | M | 90 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 9 years |
Richard J. Klein | M | 61 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 8 years |
Michael Martino | M | 68 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 10 years |
Stephen G. Sudovar | M | 77 | 4 years | |
Xavier Avat | M | - | 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 72 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- George Dunbar
- Personal Network